JIADING, SHANGHAI, CHINA, January 7, 2026 /EINPresswire.com/ -- Shanghai Trustech Technology Development Co., Ltd has ...
Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...
JIADING, SHANGHAI, CHINA, January 7, 2026 /EINPresswire.com/ -- Shanghai Trustech Technology Development Co., Ltd. - ...
AI can use sleep data from a single night to identify patterns linked to disease risk years before symptoms appear.